~4% of Americans were on GLP1 in 2024. That's a lot of people :) The good thing is that this drug was literally shown to lower MACE and all cause mortality in RCTs involving obese. I think it's a natural choice if you're struggling with chronic obesity.

Weight loss and mortality: lifestyle trials and bariatric surgery data
Argues that excess weight is the most important modifiable CVD risk factor, with lowest mortality at a BMI of 20-24. Lifestyle-driven weight loss of 5.5 kg was linked to 15% lower all-cause mortality in an RCT meta-analysis, and bariatric surgery to 38-41% lower mortality in observational pooled data.


